Thorough investigation of these and similar metabolic pathways including AMPK-dependent cellular bioenergetics within Tfh cells and in other GC T cell subsets (Ramiscal and Vinuesa, 2013) is not only warranted but also may advance current strategies for vaccine design or reveal novel therapeutic interventions for antibody-mediated immune disorders. Here, PRKAB1 is linked to immune system disorder.